We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
Cap. Flow
-$715M
Cap. Flow %
-2.15%
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$34.4M
2
FRX
FOREST LABORATORIES INC
FRX
+$32.2M
3
XOM icon
ExxonMobil
XOM
+$23.9M
4
WBD icon
Warner Bros
WBD
+$15.4M
5
RTX icon
RTX Corp
RTX
+$13.7M

Sector Composition

Rank Sector Weight
1 Technology 14.81%
2 Financials 14.8%
3 Healthcare 13.73%
4 Industrials 10.72%
5 Energy 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMPV
2201
DELISTED
Imperva, Inc.
IMPV
$513K ﹤0.01%
17,862
-90
-0.5% -$2.44K
XCRA
2202
DELISTED
Xcerra Corporation
XCRA
$513K ﹤0.01%
52,392
-10
-0% -$99
GFIG
2203
DELISTED
GFI GROUP INC
GFIG
$513K ﹤0.01%
94,835
AMWD
2204
DELISTED
American Woodmark
AMWD
$512K ﹤0.01%
13,885
+200
+1% +$6.9K
INSM icon
2205
Insmed
INSM
$21.4B
$511K ﹤0.01%
39,170
+3,195
+9% +$48.2K
EHTH icon
2206
eHealth
EHTH
$45.1M
$510K ﹤0.01%
21,124
+340
+2% +$9.28K
MFG icon
2207
Mizuho Financial
MFG
$126B
$509K ﹤0.01%
142,460
+5,000
+4% +$19.3K
GNCMA
2208
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$509K ﹤0.01%
46,689
RPTP
2209
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$508K ﹤0.01%
52,958
-1,500
-3% -$15.3K
GHDX
2210
DELISTED
Genomic Health, Inc.
GHDX
$505K ﹤0.01%
17,824
-100
-0.6% -$2.79K
CACQ
2211
DELISTED
Caesars Acquisition Company
CACQ
$504K ﹤0.01%
53,260
RENT
2212
DELISTED
RENTRAK CORP
RENT
$504K ﹤0.01%
8,276
+25
+0.3% +$1.3K
CWEI
2213
DELISTED
Clayton Williams Energy, Inc.
CWEI
$503K ﹤0.01%
5,218
-130
-2% -$15K
LF
2214
DELISTED
LEAPFROG ENTERPRISES INC.
LF
$501K ﹤0.01%
83,606
-100
-0.1% -$670
CMLS
2215
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$500K ﹤0.01%
15,516
+550
+4% +$21.8K
COBZ
2216
DELISTED
CoBiz Financial,Inc
COBZ
$500K ﹤0.01%
44,685
MRCY icon
2217
Mercury Systems
MRCY
$6.77B
$499K ﹤0.01%
45,357
+950
+2% +$10.7K
OB
2218
DELISTED
Onebeacon Insurance Group Ltd
OB
$498K ﹤0.01%
32,305
+600
+2% +$9.43K
FORM icon
2219
FormFactor
FORM
$9.38B
$497K ﹤0.01%
69,351
HHS icon
2220
Harte-Hanks
HHS
$15.9M
$496K ﹤0.01%
7,782
OPLK
2221
DELISTED
OPLINK COMMUNICATIONS INC
OPLK
$496K ﹤0.01%
29,486
CENTA icon
2222
Central Garden & Pet Co Class A
CENTA
$2.42B
$495K ﹤0.01%
77,030
BNCL
2223
DELISTED
Beneficial Bancorp, Inc.
BNCL
$495K ﹤0.01%
42,577
-110
-0.3% -$1.34K
HTLF
2224
DELISTED
Heartland Financial USA, Inc.
HTLF
$493K ﹤0.01%
20,655
I
2225
DELISTED
INTELSAT S. A.
I
$493K ﹤0.01%
28,778
-90
-0.3% -$1.63K

Similar funds

RhumbLine Advisers's Q3 2014 Portfolio in Review

As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
  • RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
  • RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
  • RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
  • RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
  • RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.

Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.